We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Home > Resources > Industry Releases > Content Piece

Cannapharma Wins UK Innovate SMART Grant

Original story from Shimadzu

Published: Mar 14, 2023   
Cannabis buds being removed from a test tube.

Image credit: iStock

Listen with
Speechify
0:00
Register for FREE to listen to this article
Thank you. Listen to this article using the player above.

The UK Innovate SMART grant is a highly competitive initiative designed to advance small and medium-sized enterprises (SMEs) and partners with investment in research and development (R&D) in order to pioneer ground-breaking products, processes, or services. 

Successful candidates are eligible for a share of up to £25 million in order to promote novel and world-leading ideas. This prestigious grant was recently awarded to Cannapharma, a market leading company in the CBD product market.

With a focus on creating products in a pharmaceutical environment, world class technology with reliability, and quality capabilities were of paramount concern to Cannapharma. As such, Cannapharma selected Shimadzu as its analytical partner to supply the trailblazing Cannabis Analyzer Liquid Chromatography instrumentation. 

Cannapharma is proud to be using Shimadzu’s state of the art LC Cannabinoid analyzer. Americo Folcarelli (CMO) “Cannapharma, with the responsibility of being the first CBD company to receive a UK Innovate SMART grant, we knew we had to ensure that we could bring our customers the highest quality products, and with Shimadzu we are sure that we can do that.”

Adam MacKenzie (COO), “When it comes to cannabinoids, there is no other company with the reputation or the quality of Shimadzu. Building our laboratory, I knew from the start that we were going to use Shimadzu. They are the only company we felt could match the standards that we uphold in all Cannapharma products.”

Shimadzu’s LC Manager Raymond Wong added, “Shimadzu are very enthusiastic to be partnered on this exciting project with Cannapharma. They have illustrated the advances that can be made in a new and innovative field and highlight the need for vigorous analytical testing for CBD products.”

This powerful collaboration, in addition to the Innovate UK SMART grant, will enable Cannapharma to conduct its cutting-edge research with confidence and with upmost certainty in its cannabinoid product ranges.


For more information on Shimadzu’s game-changing Cannabis Analyzer, click here. For information on Cannapharma and their extensive range of products, click here. 


This article has been republished from materials provided by Shimadzu. Note: material may have been edited for length and content. For further information, please contact the cited source.

 

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter

 
Advertisement